Anti-Nectin-4 Antibody (Enfortumab)
Catalog No.
F2097
Anti-Nectin-4 Antibody (Enfortumab)
Featured Products
Enfortumab is an antibody-drug conjugate (ADC) whose main component is enfortumab vedotin. It consists of the antibody enfortumab and the cytotoxic drug monomethyl auristatin E (MMAE). Enfortumab selectively delivers MMAE to cancer cells by targeting the Nectin-4 protein, thereby inhibiting the formation of microtubules, leading to cell cycle arrest and cell death. Enfortumab is mainly used to treat locally advanced or metastatic urothelial carcinoma
Quality Control & DataSheet
- View current batch:
145.44 kDa
Dry ice
1448664-46-7
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Enfortumab vedotin, Enfortumab vedotin-ejfv
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Nectin-4
Please avoid freeze-thaw cycles.